NCT01581853View on ClinicalTrials.gov

Pilot Simplification Study to Lopinavir/Ritonavir 800/200 mg Monotherapy Regimen Once Daily

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
HIV
Interventions
DRUG

Lopinavir/ritonavir 800 mg / 200mg

Lopinavir/ritonavir 800 mg / 200mg will be change from its approved posology (2 times daily)to once daily in patients with undetectable viral load and in stable treatment with Lopinavir/ritonavir 800 mg / 200mg in monotherapy for at least 6 months

Trial Locations (2)

08003

Hospital del Mar, Bercelona

08907

Hospital Universitary de Bellvitge, L'Hospitalet de Llobregat

All Listed Sponsors
lead

Daniel Podzamczer

OTHER

NCT01581853 - Pilot Simplification Study to Lopinavir/Ritonavir 800/200 mg Monotherapy Regimen Once Daily | Biotech Hunter | Biotech Hunter